SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$82.21
Tradestie Score
60
Market Cap
$994.20M
Analyst Upside
+16.9%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$230.07
|
$8.30B | 1968.1 | 59 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$70.45
|
$6.68B | - | 56 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$93.38
|
$6.64B | - | 59 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$102.87
|
$6.38B | - | 49 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$35.32
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$52.90
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.41
|
$5.95B | - | 60 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$253.56
|
$5.92B | - | 61 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$50.10
|
$5.80B | 16.8 | 67 | Compare |
More SYRE Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry